WHITTIER TRUST CO - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 119 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
WHITTIER TRUST CO ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$2,494
-16.6%
2890.0%0.00%
Q2 2023$2,991
-4.6%
2890.0%0.00%
Q1 2023$3,135
-3.3%
2890.0%0.00%
Q4 2022$3,242
+8.1%
2890.0%0.00%
Q3 2022$3,0000.0%2890.0%0.00%
Q2 2022$3,0000.0%2890.0%0.00%
Q1 2022$3,0000.0%2890.0%0.00%
Q4 2021$3,000
+50.0%
2890.0%0.00%
Q3 2021$2,000
-50.0%
2890.0%0.00%
Q2 2021$4,000
-33.3%
2890.0%0.00%
Q1 2021$6,000
+20.0%
2890.0%0.00%
Q4 2020$5,000
+25.0%
2890.0%0.00%
Q3 2020$4,000
-33.3%
2890.0%0.00%
Q2 2020$6,000
-14.3%
2890.0%0.00%
Q1 2020$7,0000.0%2890.0%0.00%
Q4 2019$7,000
+16.7%
2890.0%0.00%
Q3 2019$6,000
+20.0%
2890.0%0.00%
Q2 2019$5,000
-54.5%
289
-40.3%
0.00%
Q1 2019$11,000
-8.3%
4840.0%0.00%
Q4 2018$12,000
-25.0%
4840.0%0.00%
Q3 2018$16,000
+45.5%
4840.0%0.00%
Q2 2018$11,000
-8.3%
4840.0%0.00%
Q1 2018$12,0004840.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Link Fund Solutions Ltd 5,251,349$135,459,00069.86%
Chescapmanager LLC 949,006$24,570,0003.61%
Baupost Group 9,309,168$241,014,0002.66%
Rock Springs Capital Management LP 655,200$16,963,0000.54%
Rubric Capital Management LP 173,400$4,489,0000.51%
Newtyn Management, LLC 173,300$4,487,0000.41%
NJ State Employees Deferred Compensation Plan 38,142$988,0000.17%
King Wealth Management Group 22,500$583,0000.15%
Virtus ETF Advisers LLC 29,216$756,0000.12%
JACOBS LEVY EQUITY MANAGEMENT, INC 452,615$11,718,0000.12%
View complete list of THERAVANCE BIOPHARMA INC shareholders